Prof. Ed Boyden and Prof. Li-Huei Tsai have “found that if gamma waves through non-invasive stimulation, were put back into baseline frequency, it could slow down the process in certain brain diseases such as Alzheimer’s,” reports Hansa Bhargava for Forbes.
MIT Profs. Angela Belcher, Emery Brown, Paula Hammond and Feng Zhang have been honored with National Medals of Science and Technology, reports Michael T. Neitzel for Forbes. Additionally, R. Lawrence Edwards '76 received a National Medal of Science and Noubar Afeyan PhD '87, a member of the MIT Corporation, accepted a National Medal on behalf of Moderna. The recipients have been awarded “the nation’s highest honors for exemplary achievements and leadership in science and technology,” explains Neitzel.
Prof. Li-Huei Tsai, director of the Picower Institute, speaks with NPR host Jon Hamilton about her work identifying a protein called reelin that appears to protect brain cells from Alzheimer's. “Tsai says she and her team are now using artificial intelligence to help find a drug that can replicate what reelin does naturally,” says Hamilton.
MIT researchers have discovered how propofol, a commonly used anesthetic, works on the brain, reports Francesca Benson for IFL Science. The research studied “the differences between an awake brain and one under anesthesia by looking at the stability of the brain’s activity,” writes Bensen.
MIT scientists have discovered how propofol, a commonly used anesthetic, induces unconsciousness, reports Adam Kovac for Gizmodo. “The new research indicates that [propofol] works by interfering with a brain’s ‘dynamic stability’ – a state where neurons can respond to input, but the brain is able to keep them from getting too excited,” explains Kovac.
Prof. Emerita Mary-Lou Pardue, a cellular and molecular biologist whose work “formed the foundation for key advancements and discoveries in understanding the structure of chromosomes,” has died at age 90, reports Bryan Marquard for The Boston Globe. Pardue “was a role model of what women in science can be at a time when there weren’t a lot of those, and a trailblazer as a woman,” emphasizes Ky Lowenhaupt, manager of the Biophysical Instrumentation Facility at MIT, “but also a trailblazer as a scientist who didn’t do things along the path that other people took.”
Prof. Earl K. Miller speaks with CBS News host Susan Spencer about multitasking, fear of laziness, and the importance of downtime. “A lot of times some of your best thoughts come to you when your conscious mind is out of the way, when you allow the unconscious thoughts to bubble up,” says Miller. “And sometimes it’s good to be lazy – not lazy, but to tune out a bit and let these thoughts bubble up.”
MIT scientists have uncovered evidence that the different layers of the brain’s cortex generate different brain waves, reports Simon Makin for Scientific American. “The findings may have implications for understanding—and even treating—neuropsychiatric conditions,” Makin explains.
MIT scientists have found that a potential treatment for Alzheimer’s disease involving flickering lights and low-pitched sound could also help prevent cognitive problems after cancer treatment, reports Clare Wilson for New Scientist. The treatment is aimed at stimulating 40 Hz brainwaves, which are linked to memory processing. The results suggest targeting such “brainwaves may result in broader benefits for the brain, including increasing the activity of immune cells and, most recently, boosting its drainage system, which could help clear a toxic protein called beta-amyloid.”
Cognito Therapeutics, an MIT startup co-founded by Prof. Li-Huei Tsai and Prof. Ed Boyden, has developed a headset that uses light and sound to slow the cognitive decline in Alzheimer’s patients, reports Emily Mullin for Wired. “Cognito’s headset, dubbed Spectris, delivers flashing lights and sounds through a pair of connected glasses and headphones to stimulate gamma waves in the brain” writes Mullin. “Different types of brain waves have different paces, or frequencies. Gamma waves are fast-frequency brain waves associated with thinking skills and memory, and people with Alzheimer’s are known to have fewer of these fast brain waves.”
A new study by MIT researchers finds that an experimental Alzheimer’s treatment involving sound and light stimulation at a frequency of 40 Hz is associated with, “an increase in activity of the brain's own cleanup crew; the glymphatic system,” reports Pandora Dewan for Newsweek. The findings offer an, “exciting, non-invasive potential treatment option for patients with neurological disorders in the future,” Dewan notes.
MIT scientists have found that an experimental treatment for Alzheimer's disease involving sounds and flickering lights appears to “ramp up the brain’s waste disposal networks, which boosts the clearance of beta-amyloid and other toxic proteins that contribute to memory and concentration problems,” reports Clare Wilson for New Scientist. “Once we understand the mechanism, we can probably figure out how to further optimize this whole concept and improve the efficacy,” explains Prof. Li-Huei Tsai.
Cognito Therapeutics, founded by Prof. Ed Boyden and Prof. Li Huei Tsai, has developed a “specialized headset that delivers 40Hz auditory and visual stimulation” to the brain, which could potentially slow down the cognitive decline and neurodegeneration in Alzheimer’s disease, reports William A. Haseltine for Forbes. Prof. Li-Huei Tsai “and her team speculated that if gamma wave activity is reduced in Alzheimer’s disease, perhaps, artificially stimulating the brain may enhance synchronized firing and restore cognition,” writes Haseltine.
Cognito Therapeutics, founded by Prof. Ed Boyden and Prof. Li-Huei Tsai, is using a 40 Hzlight-flickering and auditory headset to help slow the progression of Alzheimer’s and restore cognition, reports William A. Haseltine for Forbes. “A recent pilot clinical trial found that this technology is not only safe and tolerable for home use, but also has a positive impact on reducing symptoms associated with age-related neurodegeneration,” writes Haseltine.
Researchers at MIT and elsewhere have identified key cell types that may protect the brain against Alzheimer’s symptoms, reports Sara Reardon for Nature. “Most Alzheimer’s research has focused on excitatory neurons, which relay electrical signals to activate other neurons,” explains Reardon. “But the authors found that the cells with reelin or somatostatin were inhibitory neurons, which halt neuronal communication. These inhibitory cells might therefore have a previously unknown role in the types of cognitive function that are lost during Alzheimer’s.”